#Mice Model Market Growth

[alicetleibowitz]

The global mice model market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029.

[actu24hp]

Mice Model Market Trends, Revenue, Major Players, Share Analysis & Forecast by 2027

The report offers insightful information about the market dynamics of the Mice Model market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Mice Model market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the…

[insightfulblogz]

Animal Model Market Key Drivers, Challenges, and Prominent Regions by 2032

Animal models have become indispensable in the field of biomedical research, playing a critical role in studying human diseases, drug discovery, and therapeutic development. These models mimic human physiological and pathological processes, allowing scientists to gain a deeper understanding of diseases and develop effective treatments before human trials. Animal models, which include mice, rats, zebrafish, and primates, provide valuable insights into complex biological mechanisms, genetic influences, and cellular interactions, laying the groundwork for advancements in medicine and pharmacology. By closely replicating human responses, animal models bridge the gap between laboratory research and clinical applications, enabling more accurate prediction of drug efficacy and safety.

The global animal model market has witnessed substantial growth due to increasing investments in pharmaceutical R&D and biotechnological advancements. With rising demand for personalized medicine and the need for effective treatments for conditions like cancer, cardiovascular diseases, and neurological disorders, animal models are instrumental in accelerating drug discovery and development processes. Recent technological advancements, such as genetically engineered animal models and advanced imaging techniques, have further enhanced the applicability and accuracy of animal models, making them a preferred choice for researchers across the globe.

The Animal Model Market size was estimated at USD 2.41 billion in 2023 and is expected to reach USD 4.20 billion by 2031 at a CAGR of 7.2% during the forecast period of 2024-2031.

Future Growth

The animal model market is poised for significant expansion, driven by increasing emphasis on translational research and preclinical studies. Advances in genetic engineering and molecular biology have made it possible to create animal models that exhibit human-like disease symptoms, thus improving the reliability and predictability of preclinical studies. This demand is particularly robust in the fields of oncology and neuroscience, where animal models are essential for developing groundbreaking therapies. Additionally, the rise in demand for alternative testing solutions due to stringent regulations on animal testing is expected to drive growth in innovative model development, including computational and organ-on-chip technologies, alongside traditional animal models.

Growth in the animal model market is also influenced by the rise in biomedical research funding from both governmental and non-governmental organizations. Emerging economies are increasing investments in scientific infrastructure and R&D capabilities, providing a positive outlook for the animal model market. As global focus intensifies on developing treatments for chronic diseases, the requirement for predictive and reliable animal models will only grow, creating favorable conditions for market players to expand their portfolios and reach.

Drivers

One of the primary drivers of the animal model market is the increasing prevalence of chronic diseases worldwide. With cancer, cardiovascular disorders, and metabolic diseases becoming more common, the need for reliable preclinical models has become essential in developing new drugs and therapies. Animal models allow for an in-depth understanding of disease mechanisms and therapeutic efficacy, making them critical tools in tackling these global health challenges. Furthermore, advancements in CRISPR and other gene-editing technologies have facilitated the development of animal models that closely mimic human disease conditions, leading to more accurate and predictive preclinical outcomes.

Another significant factor driving the market is the growth in pharmaceutical and biotechnological R&D activities. As companies strive to innovate, the demand for animal models that can effectively simulate human responses to drugs has increased. Regulations in various regions mandate thorough preclinical testing to ensure the safety and efficacy of new drugs, contributing to the sustained demand for animal models. Additionally, the trend towards personalized medicine has bolstered the market, as researchers require specialized models that align with specific genetic or phenotypic profiles, thereby advancing precision medicine approaches.

Key Takeaways

The animal model market is essential for biomedical research and drug discovery, offering insights into human diseases and therapeutic responses.

Genetic engineering advancements have enhanced the relevance and accuracy of animal models, expanding their use in preclinical studies.

Leading companies like Charles River Laboratories and Envigo are driving innovation in animal model development, especially in gene-editing applications.

Rising cases of chronic diseases are fueling the demand for preclinical research, positioning animal models as critical tools in medical advancements.

Regulatory requirements worldwide mandate thorough testing, increasing the reliance on animal models for safety and efficacy trials.

Get a Free Sample Copy of the Report: https://www.snsinsider.com/sample-request/3789 

Conclusion

The global animal model market is expected to witness continued growth as researchers, pharmaceutical companies, and biotechnology firms increasingly rely on animal models to accelerate therapeutic innovations. The development of genetically modified animal models, enhanced imaging techniques, and alternative testing methods is transforming the landscape of preclinical research. However, the market is also navigating ethical and regulatory considerations, which has spurred the advancement of alternative technologies that complement animal models while reducing the need for animal testing.

With an ever-growing focus on understanding complex diseases and creating personalized medicine, the animal model market will remain integral to scientific discovery and translational research. As global health challenges continue to emerge, animal models will play a pivotal role in bridging laboratory research with clinical applications, ultimately contributing to the development of safer, more effective treatments for patients around the world.

[credenceresearchdotblog]

The Rat Model Market is projected to grow from USD 1,425.98 million in 2023 to an estimated USD 2,643.74 million by 2032, with a compound annual growth rate (CAGR) of 7.10% from 2024 to 2032. The rat model market plays an essential role in preclinical research, drug development, toxicology studies, and disease modeling, making it an indispensable part of the biomedical research ecosystem. With advances in biotechnology, genetics, and pharmaceutical research, rat models have become increasingly significant due to their physiological and anatomical similarities to humans. This article delves into the dynamics of the rat model market, including its growth drivers, challenges, trends, and future prospects.

Browse the full report https://www.credenceresearch.com/report/rat-model-market

Importance of Rat Models in Research

Rat models are widely used in scientific studies for understanding human biology and disease mechanisms. They offer several advantages over other animal models, such as mice, due to their larger size, which allows for more complex surgical procedures and a more accurate collection of biological data. Moreover, rats share more similarities with humans in terms of metabolism, neurobiology, and cardiovascular systems, making them ideal for studies in oncology, neurology, and cardiology.

In addition to their biological relevance, rat models are cost-effective and have a relatively short lifespan, enabling researchers to observe the effects of treatments and interventions across an entire lifecycle. Furthermore, the availability of genetically modified rat strains, including transgenic and knockout models, has expanded the scope of research in areas like cancer, diabetes, and neurodegenerative diseases.

Market Drivers

Several factors contribute to the growing demand for rat models in biomedical research:

1. Advancements in Genetic Engineering: The ability to manipulate rat genomes has expanded the utility of rat models in research. Techniques like CRISPR/Cas9 have made it easier to create precise gene knockouts or insertions, enabling the study of complex diseases such as Alzheimer's, Parkinson's, and cardiovascular disorders.

2. Increased Drug Development Activity: With the rise of chronic diseases and an aging population, pharmaceutical companies are investing heavily in drug discovery and development. Rat models are used extensively in preclinical trials to test the safety and efficacy of new drugs before they move on to human trials.

3. Growing Demand for Personalized Medicine: The trend toward personalized medicine, which tailors treatments to individual genetic profiles, requires a deeper understanding of gene function and disease mechanisms. Rat models, particularly genetically modified ones, play a crucial role in this process by enabling researchers to explore genetic variations and their impact on disease progression.

4. Expansion of Toxicology Studies: Regulatory bodies require extensive toxicology data to approve new drugs, chemicals, and other products. Rat models are often the preferred choice for these studies due to their similarity to humans in terms of drug metabolism and organ systems.

Challenges in the Rat Model Market

Despite its many advantages, the rat model market faces several challenges:

1. Ethical Concerns: The use of animals in research has always been a controversial issue. Increasing public awareness and advocacy for animal rights have led to stricter regulations governing animal experimentation. Researchers are now under pressure to adhere to the "3Rs" principle (Replacement, Reduction, and Refinement) to minimize animal use and suffering.

2. Advancements in Alternative Models: Technological advances, such as organ-on-a-chip systems and computational modeling, offer alternatives to animal models. These in vitro models can mimic human organ systems and are being increasingly used for toxicity testing and disease research. While they are not yet a full replacement for animal models, their development poses a challenge to the growth of the rat model market.

3. High Costs and Complexities: Maintaining genetically modified rat colonies can be expensive and labor-intensive. Specialized facilities, skilled personnel, and continuous monitoring are required, which can drive up research costs. Moreover, certain diseases do not manifest in rats the same way they do in humans, which limits the effectiveness of rat models for studying specific conditions.

Market Trends and Future Prospects

The rat model market is expected to grow significantly in the coming years, driven by several key trends:

1. Expansion of Biopharmaceutical Research: With the ongoing development of biologics, cell therapies, and gene therapies, the demand for reliable animal models like rats will continue to rise. These therapies often require extensive preclinical testing to ensure safety and efficacy.

2. Emergence of CRISPR-Based Models: CRISPR technology has revolutionized genetic research, making it easier and faster to create precise genetic modifications in rat models. This trend is expected to drive the development of more sophisticated models for studying complex diseases.

3. Increased Focus on Humanized Rat Models: Researchers are developing "humanized" rat models that incorporate human genes or tissues, allowing for more accurate predictions of how treatments will affect human biology. These models are particularly valuable in immunology and oncology research.

4. Collaboration Between Academia and Industry: Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate the development and adoption of rat models. These partnerships foster innovation and help bring new therapies to market more quickly.

Key players

Charles River Laboratories

genOway

TransViragen, Inc.

Laboratory Corporation of America Holdings (LabCorp)

Janvier Labs

Taconic Biosciences, Inc.

Biomere

Cyagen Biosciences

Segments

Based on Type

Knockout Rats

Outbred Rats

Inbred Rats

Hybrid Rats

Others

Based on Application

Oncology

Neurology

Immunology

Toxicology

Others

Based on End User

Contract Research Organizations (CROs)

Academic and Research Institutes

Pharmaceutical & Biotechnology Companies

Based on Technology

Nuclear Transferase

Microinjection

Embryonic Stem Cell Technology

Others

Based on Service

Cryopreservation

Breeding

Re-derivation

Genetic Testing

Others

Based on Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report https://www.credenceresearch.com/report/rat-model-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[ankitblogs0709]

USB Hub Market Trends and Opportunities: Global Outlook (2023-2032)

The global demand for USB Hub Market was valued at USD 4551.7 Million in 2022 and is expected to reach USD 8300.8Million in 2030, growing at a CAGR of 7.80% between 2023 and 2030.

The USB hub market is growing steadily as demand for versatile connectivity solutions rises, particularly with the increase in remote work and digital device usage. USB hubs are essential accessories that expand the number of USB ports available on computers, laptops, and other devices, allowing users to connect multiple peripherals such as keyboards, mice, external hard drives, and smartphones simultaneously. With advancements in USB technology, modern hubs now support high-speed data transfer rates, power delivery for charging devices, and compatibility with USB-C, which is rapidly becoming the standard for newer devices. USB hubs are available in various configurations, from basic multi-port models to advanced hubs with features like HDMI output, SD card readers, and Ethernet connectivity, catering to diverse consumer and professional needs. Additionally, as laptops become thinner and often feature fewer ports, USB hubs offer a practical solution for users who need expanded connectivity. The market is driven by trends such as increasing digitization, growing reliance on portable devices, and the need for efficient and space-saving technology solutions, making USB hubs a valuable accessory for both personal and business users.

The USB hub market is influenced by a variety of dynamic factors, driven by trends in consumer electronics, technological advancements, and shifts in work and lifestyle habits. Key dynamics shaping the USB hub market include:

1. Rising Demand for Connectivity Solutions

As devices like laptops, tablets, and ultrabooks become sleeker and more compact, they often feature fewer built-in ports, creating a need for USB hubs to provide expanded connectivity options. This trend is especially prominent among professionals, gamers, and content creators who rely on multiple peripherals.

2. Increased Adoption of Remote Work and Digital Learning

The growth in remote work and online education has increased demand for USB hubs as users need to connect various peripherals, such as webcams, microphones, external storage, and monitors. USB hubs allow for efficient multitasking and setup flexibility, making them essential tools for home office and learning environments.

3. Advancements in USB Technology

The transition to USB-C and the proliferation of USB 3.0 and 3.1 technology enable faster data transfer speeds, higher power delivery for charging devices, and improved connectivity with modern devices. This advancement has boosted demand for USB hubs that can support these newer standards, offering higher functionality and compatibility.

4. Growing Popularity of Compact and Portable Devices

With the rise of slim, lightweight laptops and tablets that often come with limited ports, USB hubs offer a practical solution for users who require multiple connections. The shift toward portable computing devices has contributed to the demand for compact USB hubs that provide connectivity without compromising mobility.

5. Diverse Product Offerings and Customization

The market features a wide range of USB hubs tailored to various needs, from basic hubs with multiple USB-A ports to advanced models with HDMI, Ethernet, SD card slots, and even wireless charging capabilities. This diversity allows consumers to choose products based on specific needs, whether it’s for gaming, professional use, or casual use, driving market growth through segmentation.

6. Increasing Focus on Charging Capabilities

Many USB hubs now include charging capabilities, allowing users to power devices such as smartphones, tablets, and laptops. With the adoption of Power Delivery (PD) technology, USB hubs can charge high-wattage devices, adding convenience and utility for users who seek all-in-one solutions for data transfer and charging.

7. Demand from the Gaming and Content Creation Communities

Gamers and content creators often require high-performance equipment and multiple device connections. USB hubs with high data transfer rates, low latency, and additional features like HDMI output or SD card readers are in demand within these communities. This segment has driven growth for specialized hubs designed to support multimedia-intensive tasks.

8. Impact of E-commerce and Distribution Channels

The increasing accessibility of e-commerce platforms has made it easier for consumers to purchase USB hubs, contributing to market growth. Additionally, online reviews, comparisons, and product availability on various platforms allow consumers to make informed choices, driving demand for high-quality and feature-rich USB hubs.

9. Focus on Energy Efficiency and Durability

As consumers become more environmentally conscious, there is a rising demand for energy-efficient and durable USB hubs. Manufacturers are responding by producing hubs with eco-friendly materials and energy-saving features, appealing to consumers who value sustainability.

10. Competitive Pricing and Product Differentiation

The USB hub market is highly competitive, with numerous brands offering products at various price points. Companies are differentiating themselves through unique features, aesthetic design, warranty offers, and brand reputation. Competitive pricing, combined with innovative features, is crucial for capturing consumer interest in this saturated market.

11. Regional Growth and Emerging Markets

While North America and Europe remain major markets for USB hubs, emerging markets in Asia-Pacific, Latin America, and Africa are seeing rapid growth due to increasing digitization, mobile device adoption, and the rise of remote work and digital learning. This regional growth offers expansion opportunities for manufacturers.

Access Complete Report - https://www.credenceresearch.com/report/usb-hub-market

Key Players

Anker Innovations Co. Ltd

Conceptronic

Vaunix Technology Corp.

Belkin International, Inc.

Honeywell International

Texas Instruments

StarTech.com

USBGear.com

Atolla.com

Texa Instrusments

The USB hub market exhibits varying growth patterns across different regions, driven by unique economic, technological, and consumer trends. Here are key regional insights:

1. North America

Mature Market with High Demand: North America, particularly the United States, holds a significant share of the USB hub market. The high adoption of technology, strong consumer purchasing power, and an established base of technology-driven industries contribute to this region’s growth.

Remote Work and Digital Transformation: With the rise in remote work and home offices, there is increased demand for USB hubs to support multiple device connectivity. Businesses and consumers alike are adopting USB hubs to enhance productivity in home office setups.

Focus on Advanced Technology: North American consumers prefer high-performance USB hubs with the latest features, such as USB-C support, high-speed data transfer, and power delivery (PD) for charging. This trend is fueled by the widespread use of USB-C laptops, smartphones, and tablets.

2. Europe

Demand for Environmentally Friendly Products: In Europe, the market is strongly influenced by environmental concerns and stringent regulations on electronic waste. Many European consumers and businesses are seeking sustainable USB hubs made from eco-friendly materials, which has led manufacturers to innovate with recyclable and energy-efficient designs.

Remote Work and Digital Learning Adoption: Similar to North America, Europe has seen a rise in remote work and digital learning, increasing the demand for USB hubs in home office setups. Countries like Germany, the UK, and France are at the forefront of this demand.

Technology Integration and Compatibility: European consumers favor USB hubs with multi-functionality, such as those with HDMI output, Ethernet ports, and SD card readers, to simplify connectivity needs. Hubs compatible with USB-C and Thunderbolt technologies are particularly popular, reflecting the prevalence of USB-C-enabled devices.

3. Asia-Pacific

Rapid Growth and Emerging Market Potential: The Asia-Pacific region is witnessing rapid growth in the USB hub market, driven by high digital adoption rates, increasing use of portable devices, and the rise of remote work in countries like China, Japan, India, and South Korea.

Price Sensitivity and Cost-Effective Solutions: Consumers in this region often prioritize affordability, creating demand for a range of USB hubs at competitive prices. Many companies focus on producing cost-effective hubs with essential features, appealing to the region’s price-sensitive market.

Technological Innovation Hub: Asia-Pacific is home to major electronics manufacturers and technology innovators, which fosters rapid product development and quick adoption of the latest USB standards, such as USB 3.1, USB 3.2, and USB-C. High demand exists for USB hubs that support fast charging and data transfer, making the region a key hub for cutting-edge product offerings.

4. Latin America

Growing Digitalization and Tech Adoption: As digitalization efforts increase across Latin American countries, demand for USB hubs is growing, particularly among younger consumers and tech-savvy professionals. E-commerce growth in countries like Brazil and Mexico is also making these products more accessible.

Economic Constraints and Focus on Affordability: While there is growing demand for connectivity solutions, Latin American markets are often more price-sensitive. This trend favors the sale of basic, functional USB hubs that meet essential connectivity needs without additional high-end features.

Expanding Remote Work Infrastructure: With more companies offering flexible work options, the need for home office setups that include USB hubs is on the rise. The trend is expected to continue as digital transformation progresses across the region.

5. Middle East and Africa

Emerging Demand for Connectivity Solutions: The USB hub market is gradually expanding in the Middle East and Africa as internet penetration and the adoption of digital devices increase. Demand is particularly notable in urban areas where tech-savvy consumers and businesses seek enhanced connectivity.

Focus on Affordable and Durable Products: In this region, there is a preference for durable and affordable USB hubs that can meet basic connectivity needs. Consumers and businesses in the Middle East and Africa prioritize practicality, often favoring robust and cost-effective solutions.

Growth Opportunities in Tech-Driven Economies: Countries like the UAE and Saudi Arabia are seeing higher demand due to their focus on digital transformation and smart city initiatives. These tech-driven economies are adopting more advanced USB hubs to support professional environments and smart technologies.

Segmentation

By Type of USB Hub:

USB 2.0 Hubs

USB 3.0 Hubs

USB 3.1 and USB 3.2 Hubs

USB-C Hubs

By Port Configuration:

4-Port USB Hubs

7-Port USB Hubs

10-Port or Higher USB Hubs

By Powered vs. Unpowered Hubs:

Powered USB Hubs

Unpowered USB Hubs

By Specialized USB Hubs:

Gaming USB Hubs

Industrial USB Hubs

USB Hubs with Card Readers

Travel-Friendly USB Hubs

By Price Range:

Economy USB Hubs

Mid-Range USB Hubs

Premium USB Hubs

By Application:

Home and Office

Gaming

Industrial and Commercial

Photography and Multimedia

By Distribution Channel:

Online Retail

Brick-and-Mortar Retail

Browse the full report –  https://www.credenceresearch.com/report/usb-hub-market

Contact Us:

Phone: +91 6232 49 3207

Email: sales@credenceresearch.com

Website: https://www.credenceresearch.com

[healthcaremarketanalysis]

In Vivo Toxicology Market worth $6.6 billion by 2025

The global in vivo toxicology market in terms of revenue was estimated to be worth $5.0 billion in 2020 and is poised to reach $6.6 billion by 2025, growing at a CAGR of 11.5% from 2020 to 2025. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

Download PDF Brochure:

In Vivo Toxicology Market Dynamics

Driver: Exclusive in vivo toxicology tests

With the introduction of alternative methods such as in vitro and in silico toxicology testing, several toxicology tests are conducted through laboratory methods. However, certain tests are exclusive to in vivo toxicology testing, such as tests for carcinogenicity, developmental (including teratogenicity in offspring) & reproductive toxicity, mutagenicity, and neurotoxicity.

The growing focus on carcinogenic toxicity tests for drugs is likely to propel the use of animal models for in vivo toxicology testing. According to the Cancer Research Institute, the number of active drugs in development grew by more than 90%, to 3,876 in 2019. Long-term rodent carcinogenicity studies for assessing the carcinogenic potential of drugs in humans are currently being examined.

Restraint: Alternatives to animal testing

Development of improved non-animal In vitro models is expected to restrain the growth of in vivo toxicology market. Such models have gained immense traction in toxicology testing across human stem cells, drugs. cell culture models, and high-throughput testing. Additionally, the increasing adoption of alternative toxicology testing solutions expected to limit the demand for animal models.

Challenge: Regulations and laws for the ethical use of animals in research

Implementing laws and regulations for animal protection and welfare has resulted in restrictive practices and bans on animals for different purposes. In the last five years, many countries have banned the use of animals in the cosmetic industry.

Moreover, institutes funded by the National Institutes of Health (NIH) are required to adhere to Public Health Service (PHS) policy and follow the Guide for the Care and Use of Laboratory Animals developed by the Institute for Laboratory Animal Research (ILAR). To increase the chances of funding, research institutes seek accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC), a privately funded membership-based organization.

Opportunity: Rising demand for humanized animal models

Humanized animal models are important tools for conducting preclinical research to gain insights into human biology. These models are developed through the engraftment of human cells or tissues, leading to the expression of human proteins in animals.

Humanized mice are increasingly being used as models for biomedical research applications, such as cancer, infectious diseases, HIV/AIDS, regenerative medicine, and hepatitis. In March 2019, the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the US Department of Health and Human Services, announced funding for projects to conduct detailed characterization, direct comparisons, and further development of humanized immune system (HIS) mouse models. The need to identify the actual effects of drugs on humans, as well as the growing focus on studying human-specific infections, therapies, and immune responses, is promoting the development and use of humanized animal models

By Product, the consumables accounted for the largest share of the in vivo toxicology market

Based on the product, the market is categorized into consumables and instruments Reagents & kits accounted for the largest share of the consumables segment. Wide use of immunoassays for antibody analysis in biological samples is the key attributive factor to the segment growth. Rapid immunoassay (RIA) is an emerging technique that quantifies antigen concentration. Advantages associated with this technique such as, easy automation, high senstitvity, and enhanced signal detection is expected to fuel its adoption in the future.

By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market

Based on toxicity endpoint, the global market is segmented into systemic toxicity, immunotoxicity, genotoxicity, carcinogenicity, developmental & reproductive toxicity (DART), and other toxicity endpoints. Immunotoxicity a result of the adverse effects arising from the immune system functions caused due to excessive drug exposure, biologics, or exposure to chemical compunds. Exposure to benzene, asbestos, and halogenated aromatic hydrocarbons may lead to immunosuppression in humans.

By test type, chronic toxicity testing segment accounted for the largest share of the in vivo toxicology market

Based on test type, the global market is segmented into chronic, sub-chronic, acute, and sub-acute test type. Chronic toxicity tests are carried out with a minimum of one rodent and one non-rodent species. The test compound is administered over more than 90 days, and the animals are observed periodically. A chronic toxicology study provides inferences about the long-term effect of a test substance in animals, and it may be extrapolated to the human safety of the test substance. Hence, drugs used for longer-duration therapy such as chemotherapeutic agents, anti-cancer, anti-convulsive, anti-hypertensives and anti-arthritis require chronic toxicity testing further driving the segment growth.

By testing facility, outsourced testing facilities segment accounted for the largest share of the in vivo toxicology market

Based on the testing facility, the global market is segmented into outsourced testing facilities and in-house testing facilities. The outsourced testing facilities segment accounted for the largest market share in 2020 and is expected to maintain its dominance throughout the forecast period. High focus on cost curtailment and increasing need to access skilled labor boost the segment growth.

By end user, academic and research institutes segment accounted for the largest share of the in vivo toxicology market

Based on the end user, the global market has been broadly segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and other end users. As per an article published in 2019, the number of partnerships amongst academic and corporate institutions has increased significantly from 2016-2019 and this trend is set to continue in the near future. More than 90% of the research papers published by key entities were in collaboration with academic/research institutes and or government labs.

North America accounted for the largest share of the in vivo toxicology market in 2020

North America, includes the US and Canada, accounted for the highest market share in the in vivo toxicology market. High demand for personalized medicines is the key driving factor of the North America market. Additioally, the expansion of the stem cell research sector in Canada, which is primarily driven by large-scale investments due to the implementation of the Canadian Stem Cell Strategy and Action Plan is another contributing factor to the North America market. In 2020, a grant of USD 675,000 to the Stem Cell Network for developinga potential cell therapy against SARS-CoV-2 infection.

Key Market Players

The major players operating in this market are by Charles River Laboratories (US), The Jackson Laboratory (US), Envigo (US), Taconic Biosciences, Inc. (US), and JANVIER LABS (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Bruker Corporation (US), PerkinElmer (US). Other prominent players include Merck KGaA (Germany), GE Healthcare (US), and Bio-Rad Laboratories (US), genOway (France), Cyagen Biosciences (US), GVK BIO (India), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioServices (France), Ozgene Pty Ltd. (Australia), Harbour BioMed (US) among others.

Recent Developments

In 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.

In 2020, Taconic entered into an agreement with the University of Texas Medical Branch to distribute humanized ACE2 mice for COVID-19 research.

In 2020, The Jackson Laboratory started the production of ACE2 mice to support the research on COVID-19.

In 2020, Danaher Corporation acquired GE Healthcare’s Life Sciences business.

In 2020, Thermo Fisher launched Orbitrap Exploris 240 and Orbitrap Exploris 120 mass spectrometers.

In 2020, Waters Corporation announced the establishment of Immerse Cambridge, a research laboratory in the heart of Cambridge’s Kendall Square. Immerse Cambridge will serve as a strategic, collaborative space in the community, where Waters can partner with academia and research to accelerate the next generation of scientific advancements.

[bhushans]

The Future of Autism Care: Global Animal Model Market

The animal model market is on a promising trajectory, with revenue estimated to reach around USD 1,943.3 million in 2024. Leveraging the advantages of shorter life cycles, high genotype resemblance, and ease of laboratory testing, animal models are pivotal in advancing scientific and medical research.

According to the latest demand analysis report, the market is expected to grow at a steady Compound Annual Growth Rate (CAGR) of 6% over the next decade. By 2034, the global animal model industry is projected to achieve a remarkable valuation of nearly USD 3,476.8 million.

This growth reflects the essential role animal models play in driving breakthroughs in healthcare, pharmaceuticals, and biotechnology. From developing new treatments to understanding complex diseases, animal models are at the forefront of innovation and discovery.

Request Your Detailed Report Sample With Your Work Email: https://www.futuremarketinsights.com/reports/sample/rep-gb-3141

Animal models play a crucial role in various stages of drug development, from initial discovery to preclinical and clinical trials. Their use enables researchers to understand biological mechanisms, test the efficacy and safety of potential treatments, and evaluate disease progression and therapeutic interventions.

Key Takeaways from the Animal Model Market Study Report:

The market in North America is expected to account for over 40% of the global market share in 2024, followed by Europe.

The United States creates the most demand for preclinical animal models in North America and is poised to advance further with a 6.7% CAGR through 2034.

Germany is expected to continue to be the most lucrative market for animal models in Europe, exhibiting a growth rate of 8.2% through 2034.

The United Kingdom is another notable market for the use of laboratory animals, which is likely to exhibit a 6.6% CAGR till 2034.

China is the leading supplier of animal models for preclinical research in Asia and is expected to witness a 6.1% CAGR through 2034.

Competitive Landscape for the Animal Model Market Participants:

The competition in the animal model industry is highly concentrated, and many contemporary participants are focused on the rat and mouse model segment. However, the approval and adoption of many other animal species, like pigs or non-human primates, is expected to diversify the market by increasing animal model suppliers.

“Rising demand for biomedical research animals and their increased use in the development of personalized medicine has created new opportunities for existing animal model suppliers. Further, more government support in the form of funding and subsidies for supplying laboratory animals in pharmacological studies has encouraged many start-ups in recent years,” – says a lead analyst at FMI.

Key Players Profiled in the Animal Model Market Report:

Charles River Laboratories International, Inc.

Horizon Discovery Group plc.

The Jackson Laboratory

Taconic Biosciences, Inc.

Genoway SA

Eurofins Scientific SE

Crown Bioscience, Inc.

Envigo CRS SA

Transposagen Biopharmaceuticals, Inc.

Key Segments Covered by Animal Model Industry Survey Report:

By Species Type:

Rats

Mice

Guinea Pigs

Rabbits

Monkeys

Dogs

Pigs

Cats

Other Species

By Application:

Basic and Applied Research

Drug Discovery and Development

Other Applications

By End User:

Academic & Research Institutions

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organizations (CROs)

Other End Users

By Region:

North America

Latin America

Europe

East Asia

South Asia and Pacific

Middle East and Africa (MEA)

[wellnessweb]

Animal Model Market Size: Current Trends and Future Forecast

The Animal Model Market size was estimated USD 2.41 billion in 2023 and is expected to reach USD 4.20 billion by 2031 at a CAGR of 7.2% during the forecast period of 2024-2031. The Animal Model Market is experiencing robust growth, driven by the increasing demand for preclinical research in drug development and biomedical studies. Researchers rely on animal models, such as mice, rats, and zebrafish, to simulate human disease conditions and evaluate the efficacy and safety of new treatments. Advances in genetic engineering and the rising prevalence of chronic diseases are further propelling market expansion. Additionally, regulatory agencies' stringent guidelines on drug testing necessitate extensive animal testing before clinical trials. The market is also witnessing innovation in non-traditional animal models and alternative methods aimed at improving translational accuracy and reducing ethical concerns.

Get Sample Of The Report @ https://www.snsinsider.com/sample-request/3789

Market Scope & Overview

You are entitled to an exclusive chapter and discussion on the most recent scenario, the economic downturn, and the effects of COVID-19 on the entire industry in the most recent version of this market research report. The research report focuses on a number of important factors, such as R&D, partnerships, contracts, product launches, joint ventures, and the major players in the Animal Model Market's domestic and global expansion.

The market research report will also offer qualitative data on the sector's potential turnaround date and potential actions that industry players might take to address the current situation. Industry growth trends, business policies, industrial regulations, regional industrial layout characteristics, and key business product dynamics are all taken into account by Animal Model Market research.

Market Segmentation Analysis

By Type

Mice

Rat

Guinea Pigs

Rabbits

Hamsters

Others

By Application

Cancer

Immunological Disease

Infectious Disease

Others

By End User

Pharmaceutical & Biotechnology Companies

Academic Research Institute

Contract Research Organization

Covid-19 Impact Analysis

We are closely observing market trends and consumer industry behavior as concern over the novel coronavirus (COVID-19) spreads throughout the world. We then evaluate the most recent Animal Model Market trends and forecasts while taking into account the effects of this epidemic.

Regional Outlook

In order to take into account the many facets of this market, the research is divided into separate sections. By considering the pipeline of projects and long-term contracts for the business, it also looks ahead and anticipates growth. The forecast is evaluated in relation to the size and revenue of the market. SWOT analysis is one of the methods used to evaluate the Animal Model Market  research report.

Competitive Analysis

Key insights into the market drivers and restraints, the major market players in this industry, the entire analysis of market segmentation, and the competitive analysis of the key firms involved are provided by the Animal Model Market research. The development of sales, marketing, advertising, and promotion strategies requires the use of market research reports.

Key Questions Answered in the Animal Model Market Report

What are the market's main growth prospects going forward?

What are the target market's dimensions and its potential for future growth?

What strategies are most successful for maintaining industry competition?

Conclusion

The development of strategies to gain a competitive edge in the global market and the identification of potential market opportunities will be aided by Animal Model Market market research for industry participants.

Read Full Report @ https://www.snsinsider.com/reports/animal-model-market-3789

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

BOTOX Market Growth

Botulinum Toxin Market Growth

Bovine Mastitis Market Growth

Brain Tumor Drugs Market Growth

Breast Cancer Therapeutics Market Growth

[trawexonline]

Travel Technology Companies

Travel Technology Companies-Trawex

Comprehensive Online Travel Portal Software to your business.

Trawex is one of the leading Travel Technology Companies offering consultancy services to airlines and travel agents. It specializes in development, marketing and support of travel technology software and other travel industry solutions.

Since its commencement, we have always believed in and have always provided the most appropriate solution that suits the needs of customers, which when experienced as a success, becomes the best travel technology company that could have been asked for.

Trawex takes pride in the fact that some of the best-brains and most talented personalities are working behind the scenes on the latest technologies and infrastructure to deliver result-oriented solutions.

Trawex's keen focus on traveler intent and big data has allowed it to concentrate completely on the rapidly growing online travel sector, which comprises over 1/3rd of all e-commerce transactions.

As travelers are generally comfortable, educated and tech-savvy, wielding significant purchasing power and consistently demonstrating demand for new products, this is an attractive audience to marketers.

Trawex combines unique traveler profiles with billions of intent data points from traveler's past online behaviours and current actions.

These curated anonymous data profiles are combined with powerful travel technology and algorithms to engage consumers across multi-screen and multi-channel touchpoints - such as targeted display, dynamic creative, video, Facebook, mobile, online and print boarding passes - in the travel planning and purchase cycle, optimizing the marketing message for the right person at the right time and in the right medium.

Practicing and Leveraging on these three simple principles, Trawex believes in providing the most appropriate travel technology solution in the best possible manner and to do that it has chosen to remain lean and thin, thus giving itself the agility to move quicker than the typical process is driven service providers.

We understand in providing the best services, and effective marketing strategies. We provide the best suggestions and valuable tips for a perfect website in mounting your business to success.

Travel Technology Can Transform Your Business

Trawex best travel technology company providing the best technology solutions and delivered over 150 projects with the help of travel developers with clients across the globe.

Our travel industry software is specially customized for travel aggregators, DMC’s, travel management companies, B2B & B2C travel agencies, tour operators and travel agents.

At Trawex our mission is simple. Our goal is to transform the company of leisure travel by equipping bookers with the most advanced booking and distribution software in the world.

Our team is committed to offering you with the most up-to-date, state-of-the-art transport equipment accessible on the market through ongoing development.

It enables travel businesses to connect online within one platform to company associates (B2B Agents), retail clients (B2C) and distributors.

We integrated the SAAS-based model to decrease implementation time, provide high efficiency, zero downtime, very scalable, free upgrade characteristics, and extremely guaranteed.

We know the travel market's requirements in various geographies and uniquely equipped to deliver the best products on the market in the class in the shortest time.

We connected with top travel aggregators, global systems of distribution and DMCs. We focus on technology and innovation to develop and deliver solutions for world-class travel technology to global travel agents, DMCs and MICE Company.

Travel Technology Solutions for Business Growth

Trawex is the best web-based online booking platform to give you seamless, efficient solutions for your Business Travel online bookings.

Our B2C & B2B travel agency software & tour operator software is an all-in-one suite to automate the travel business process from content acquisition all the way to the distribution process.

You will find reliable, efficient and cost-effective travel software solutions customized to your needs. We offer you a single interface to access GDS and Non-GDS services.

Trawex is the best Travel Technology Company is embedded with the essence of Travel Technology. Our engineering team is focused on providing a scalable and efficient technology platform that can be the development engine for aspiring travel businesses.

Trawex develops best hotel management software for travel agencies, our hotel management system works with your solutions to make more effective.

Our inventory in the hotel management system software automatically updates on all the channels. Our Airline Ticket reservation System is a part of the Airline Reservation System and which is one of the earliest changes to improve efficiency.

Our airport reservation system contains airline plans, fare tariffs, travel reservations, and ticket records.

We are specialized in smart solutions that have a high degree of adaptability within the travel domain to different business processes.

We have a wide variety of exclusive internet travel reservation engines for internet travel agencies (OTA's) & travel leadership businesses (TMC's).

It offers multiple GDS connections (such as Sabre, Galileo, Word span, etc.) and third-party providers to collect global material for various facilities such as flight.

Back office travel agency software fully automates the whole reservation system to handle various channels of revenues (B2C, B2B, B2B2B, B2B2C).

We supply travel booking and booking facilities in B2B & B2C mode for flights. We have more than 30 Travel XML providers integrated into our OTA platform.

Tour Operator Module allowing officials to ship contract prices from flights and OTA on mobile so that clients can use their smartphones to plan for flights. Our customers are also provided mobile apps for these solutions.

Here, offer a variety of travel technology products to empower travel agencies and vendors to tour operators with the correct solutions and provide our customers with the correct instruments to assist them to provide their customers with an improved travel reservation experience.

We provide a supplier of transport, autonomous restaurants, and a flight booking engine. We assist automate companies and streamline employees, corporate, B2B, B2C, and mobile booking specifications.

Effective use can be made of Trawex web services where the customer wants to operate on a single XML standard and can readily incorporate the service features with minimal effort into their implementation.

Trawex is the leading in Travel Technology Solutions, offering B2B (Agents), B2C (Customers) & White Label Travel Portal with GDS and third-party APIs integration.

We empower tour operators, B2B & B2C travel agencies, aggregate, as well as startup travel companies globally by offering revolutionary solutions.

We can be designed and develop a fully customized travel portal to empower your company. You will be able to deliver online travel bookings beyond your customers’ anticipation with a seamless and impressive interface.

We offer online travel deals channels B2C, B2B, B2E, B2B2C, and B2B2B travel gateways, and these B2C set-out entries can consolidate to different APIs for flights, lodgings, autos, transports for constant stock.

We create XML based travel sites for movement specialists, visit administrators, Corporate and Start-Up movement organizations.

Our B2C web-based Booking System offers the correct devices that influence the booking to work quicker and less complex for a wide range of customers - corporate or end-clients.

Our B2C Portal Solution is intended for organizations expecting to expand productivity by offering inventories specifically to clients. We can develop a user-friendly online airline reservation system for you.

When you select an airline reservation system. We provide you with a suite of connectivity solutions to ensure the best quality connection and coverage by meeting all your business needs, including, Revenue management, PMS (Property Management System), and, Channel management, and secure payment gateway options.

Faster result-oriented Flight Booking engine helps to increase the revenue of the travel agency. It has been in the business of building high-performance e-Commerce websites for SMB to Enterprises almost a year ago.

We have built our software on the latest technology we always believe technology is a game-changer for travel agency software, mid-office, B2B, B2C, Corporate Booking Engine.

Our Support for the Customer is always on priority. We know if clients/partner growth will help to grow us.

For more details, Pls visit our website:

[sophiareddy123]

The Animal Model Market is Segmented by Animal Type (Mice, Birds, Fish, Cattle, and Other Animal Types), Technology (CRISPR, Embryonic Stem Cell Injection, Nuclear Transfer, and Other Technologies), Application (Oncology, Cardiovascular, Neurology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Download Free Sample Report - Animal Model Market

[credenceresearchdotblog]

The Patient Derived Xenograft Model Market is projected to grow from USD 120 million in 2024 to an estimated USD 443.474 million by 2032, with a compound annual growth rate (CAGR) of 17.75% from 2024 to 2032.The patient-derived xenograft (PDX) model market has grown significantly in recent years, driven by the rising demand for personalized cancer therapies, increased prevalence of cancer, and ongoing advancements in biotechnology. PDX models involve the implantation of human cancer tissues into immunodeficient mice, allowing researchers to study tumor behavior, drug response, and therapeutic efficacy in a biological context closely resembling human conditions. This powerful tool has proven pivotal in translational cancer research and preclinical drug testing.

Browse the full report at https://www.credenceresearch.com/report/patient-derived-xenograft-model-market

Market Overview and Key Drivers

The global PDX model market is expanding at a considerable pace, with key drivers being the increasing incidence of cancer worldwide and the limitations of traditional cancer models, such as cell cultures and genetically engineered models, which often fail to accurately replicate the complex microenvironment of human tumors. The growing emphasis on personalized medicine has bolstered the demand for PDX models, which allow researchers to tailor treatments to specific genetic and phenotypic tumor characteristics. These models enable a more accurate prediction of how a patient's tumor will respond to different therapies, facilitating more targeted and effective treatments.

According to recent market reports, the PDX model market is projected to grow at a compound annual growth rate (CAGR) of over 12% between 2023 and 2030. This rapid growth is supported by advances in molecular biology, genomics, and bioinformatics, which have enabled deeper insights into cancer biology and the development of more sophisticated PDX models.

Technological Advancements and Opportunities

Technological advancements in the field of PDX models are enhancing their utility and accuracy. One such advancement is the development of humanized PDX models, where human immune cells are introduced into the immunodeficient mice, creating a more realistic tumor-immune system interaction. This advancement is particularly important for studying the effects of immunotherapies, which have revolutionized cancer treatment in recent years. The incorporation of next-generation sequencing (NGS) technologies into PDX model research is also enabling the identification of specific genetic mutations driving tumor growth, providing insights into potential drug targets.

Moreover, the rising adoption of organoid-based PDX models, which allow for the study of tumor development in a three-dimensional context, is offering new opportunities for drug screening and personalized treatment approaches. These innovations are expected to drive further growth in the PDX model market by improving the accuracy and predictability of preclinical studies.

Challenges

Despite the growing adoption of PDX models, several challenges remain. One of the main limitations is the high cost and time required to establish and maintain PDX models, making them less accessible to smaller research institutions. Additionally, while PDX models offer a more accurate representation of human tumors than traditional models, they still do not fully replicate the complexity of human cancer biology, particularly in terms of the tumor microenvironment and immune system interactions.

Key Player Analysis:

Abnova Corp.

Altogen Labs

Charles River Laboratories

Crown Bioscience

Envigo

Hera Biolabs

Oncodesign

The Jackson Laboratory

WuXi AppTec

XenTech

Segmentation:

By Tumor Type 

Lung Cancer

Pancreatic Cancer

Prostate Cancer

Breast Cancer

Other Cancer

By Model Type 

Mice

Rats

By End-user 

Pharmaceutical and Biopharmaceutical Companies

Academic & Research Institutes

CROs & CDMOs

By Geography

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/patient-derived-xenograft-model-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com